Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Asset Resilience Ratio

Latest as of March 2024: -0.13%

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has an Asset Resilience Ratio of -0.13% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥-2.77 Million

≈ $-404.62K USD Cash + Short-term Investments

Total Assets

CN¥2.19 Billion

≈ $320.38 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2023)

This chart shows how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's Asset Resilience Ratio has changed over time. Check 002864 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shaanxi Panlong Pharmaceutical Group Lim stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-2.77 Million	-0.13%
Total Liquid Assets	CN¥-2.77 Million	-0.13%

Asset Resilience Insights

Limited Liquidity: Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A maintains only -0.13% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Industry Peers by Asset Resilience Ratio

Compare Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2019–2023)

The table below shows the annual Asset Resilience Ratio data for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	-0.13%	CN¥-2.87 Million ≈ $-419.60K	CN¥2.13 Billion ≈ $310.96 Million	+0.47pp
2022-12-31	-0.61%	CN¥-11.77 Million ≈ $-1.72 Million	CN¥1.93 Billion ≈ $282.53 Million	-0.72pp
2021-12-31	0.11%	CN¥1.48 Million ≈ $217.12K	CN¥1.33 Billion ≈ $194.65 Million	-5.29pp
2019-12-31	5.41%	CN¥50.21 Million ≈ $7.35 Million	CN¥928.88 Million ≈ $135.92 Million	--

pp = percentage points

About Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A

SHE:002864 China Drug Manufacturers - Specialty & Generic

Market Cap

$324.89 Million

CN¥2.22 Billion CNY

Market Cap Rank

#14329 Global

#4252 in China

Share Price

CN¥20.89

Change (1 day)

+0.97%

52-Week Range

CN¥20.18 - CN¥39.20

All Time High

CN¥74.44